Intuitive Surgical, Inc. Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $11B+32.1% YoYTTM through 30 Jun 2026
Net Income $3.1B+35.1% YoYTTM through 30 Jun 2026
Free Cash Flow $3.2BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 66.0% |
| EBITDA Margin | 33.4% |
| Operating Margin | 29.3% |
| Net Margin | 28.5% |
Returns
16.0%ROE
14.1%ROA
16.0%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio5.12x
Net Debt-$5.9Bnet cash position
Cash & Equivalents$2.8B
Quality Metrics
Altman Z-Score35.49
Piotroski F-Score7 / 9
FCF Margin29.2%
Rule of 4035.9
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $10.1B
Diluted EPS$8.72TTMFY2025: $7.87
Dividend
No dividend
Capital Allocation
R&D Spend$1.4B
Capex Intensity4.4%
Segment Performance
Figures as of 31 Dec 2025
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Instruments and Accessories | $6B | +19.0% | |
| Systems | $2.5B | +26.0% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.